Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia

Amit K Mitra1, Deepak M Gangahar, Devendra K Agrawal

  • 1Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE 68178, USA.

Insights

Coronary artery disease causes graft restenosis through intimal hyperplasia (IH). Understanding IH's complex cellular and molecular factors is crucial for developing effective treatments to improve vein graft patency.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Surgical Research

Background:

  • Coronary artery disease (CAD) is a major global health issue, often requiring surgical intervention like coronary artery bypass grafting (CABG).
  • Vein graft restenosis, characterized by intimal hyperplasia (IH), significantly reduces graft patency and long-term patient outcomes.
  • The precise pathophysiology of IH remains incompletely understood, despite implicated growth factors and pathways like PI3K-Akt.

Purpose of the Study:

  • To critically evaluate and synthesize existing literature on the factors contributing to intimal hyperplasia (IH) in vein graft restenosis.
  • To elucidate the complex cellular and molecular mechanisms underlying IH development.
  • To identify gaps in knowledge and highlight areas for future research to improve therapeutic strategies.

Main Methods:

  • Comprehensive literature review and critical appraisal of published studies on vein graft adaptation and restenosis.
  • Analysis of cellular and molecular components involved in intimal hyperplasia (IH) formation.
  • Synthesis of information on growth factors, cytokines, and signaling pathways implicated in IH.

Main Results:

  • Intimal hyperplasia (IH) involves intricate interactions between vessel wall cells, leukocytes, and the coagulation cascade.
  • Smooth muscle cell phenotypic modification and migration are central to lesion formation, potentially driven by immune responses.
  • While pathways like PI3K-Akt are implicated, many contributing factors and their interrelationships in IH remain to be fully elucidated.

Conclusions:

  • A deeper understanding of early vein graft adaptation is essential for improving long-term graft survival.
  • Elucidating the multifaceted pathophysiology of intimal hyperplasia (IH) is key to developing novel therapeutic interventions for vein graft restenosis.
  • Further research is needed to connect established and emerging factors to develop more effective treatments for preventing graft occlusion.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Varicose Veins I: Introduction01:26

Varicose Veins I: Introduction

Varicose veins, or varicosities, are abnormally dilated and twisted superficial veins caused by venous valve incompetence. This condition commonly affects the lower extremities, especially the saphenous veins, due to the higher pressure from prolonged standing and walking. However, varicosities can also occur in other areas, such as the esophagus, vulva, spermatic cords, and anorectal region.Etiology and typesPrimary varicose veins, often idiopathic, are more common in women due to inherent...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...